研究実績

Multi-center, phase II study for combination therapy with paclitaxel/doxifluridine to treat advanced/recurrent gastric cancer showing resistence to S-1: Final results (OGSG0302)

Takiuchi H, Imamura H, Imano M, Kimura Y, Ishida H, Nakane Y, Tsujinaka T, Narahara H, Morimoto S, Furukawa H. (2007) .Multi-center, phase II study for combination therapy with paclitaxel/doxifluridine to treat advanced/recurrent gastric cancer showing resistence to S-1: Final results (OGSG0302). 43rd annual meeting of American society of clinical oncology (ASCO).

前の記事 次の記事 一覧ページへ戻る